Year: 2025
Type: article
Abstract: The article analyzes current concepts of the pathogenesis, diagnosis, and impact on the prognosis of metabolic dysfunction-associated steatotic liver disease (MASLD) in metabolic syndrome. An overview of current diagnostic potential, non-drug and drug therapy for MASLD is provided, as well as an overview of the impact of therapy for comorbidities on its course.
Source: Russian Journal of Cardiology
Authors: O. M. Drapkina, S. V. Nedogoda
Institution: Volgograd State Medical University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4414376481